Možné imunologické důsledky B cílené imunoonkologické léčby

Warning

This publication doesn't include Faculty of Education. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Title in English ossible immunology consequences of targeted B cell immunooncological therapies
Authors

HLAVÁČKOVÁ Eva KŘENOVÁ Zdenka ŠTĚRBA Jaroslav

Year of publication 2018
Type Conference abstract
MU Faculty or unit

Faculty of Medicine

Citation
Description Theres is an rising number of secondary antibody deficiency patients after B cell targeted therapies. The patients should be regullary monitored during and after the treatment. Prophylactic antibiotics and IVIG shoul vbe administered when indicated.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.